Package 0052-0602-02

{"route": ["INTRAVESICAL"], "spl_id": "21f6d4ee-8165-4c60-9603-67580f1e9f70", "openfda": {"nui": ["N0000183904", "N0000183364", "M0022454", "M0002239", "N0000183906", "N0000183884", "N0000009357"], "upc": ["0300520602020"], "unii": ["2XQ558L16Z"], "rxcui": ["213744", "1653484"], "spl_set_id": ["c9b74876-e665-442b-87ad-b7333bc9a67a"], "pharm_class_cs": ["Vaccines, Attenuated [CS]", "BCG Vaccine [CS]"], "pharm_class_pe": ["Actively Acquired Immunity [PE]", "Increased Macrophage Proliferation [PE]", "Increased Immunologically Active Molecule Activity [PE]"], "pharm_class_epc": ["Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]", "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0052-0602-02)  / 50 mL in 1 VIAL (0052-0602-01)", "package_ndc": "0052-0602-02", "marketing_start_date": "19900824"}], "brand_name": "TICE BCG", "product_id": "0052-0602_21f6d4ee-8165-4c60-9603-67580f1e9f70", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Actively Acquired Immunity [PE]", "BCG Vaccine [CS]", "Increased Immunologically Active Molecule Activity [PE]", "Increased Macrophage Proliferation [PE]", "Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]", "Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]", "Vaccines", "Attenuated [CS]"], "product_ndc": "0052-0602", "generic_name": "BACILLUS CALMETTE-GUERIN", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICE BCG", "active_ingredients": [{"name": "BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN", "strength": "50 mg/50mL"}], "application_number": "BLA102821", "marketing_category": "BLA", "marketing_start_date": "19900824", "listing_expiration_date": "20261231"}